Trump is unlikely to end Medicare drug price talks — here’s what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper…
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper…
Perhaps unsurprisingly, the biggest winner of the trade tariffs is likely to be the U.S. ...
Elon Musk and his DOGE team are tasked by President Donald Trump to find government spending inefficiency and cut federal…
The sale included a mansion swap, bespoke furniture, elaborate chandeliers, art, alcohol and even a miniature Ferrari 250 Testa Rossa…
The oft-maligned skinny jean has crept back onto the runway and is headed for a comeback as soon as this…
Two exchange-traded fund experts deliver plays that should deliver multi-year gains. ...
Philadelphia Super Bowl and World Series wins have historically coincided with stock market calamity. But these types of "fun" indicators…
Meta, Amazon, Alphabet and Microsoft intend to invest as much as $320 billion this year into AI advancement technologies. ...
Several beauty stocks tanked this week, as companies like E.l.f. Beauty and Estee Lauder reported disappointing earnings and cut guidance.…